ArticlePhysics and imaging in radiation oncology2026
Translational barriers to digital twins in radiation oncology.
Article in Physics and imaging in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Optimizing the delivery of radiotherapy with artificial intelligence.Nature reviews. Clinical oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Digital twin research in radiation oncology has expanded rapidly across multiple domains, yet the field lacks definitional consensus and validated translational frameworks. A systematic search (PubMed, Scopus and Web of Science - September 2025) identified 903 records and six original studies met inclusion criteria. Appraisal of the available original studies revealed three recurring translational barriers: misuse of the term "digital twin" for virtual humans or patient-specific predictive models; overreliance on internal or in-silico validation; and limited benchmarking against clinically established alternatives. Progress toward clinical translation requires disciplined nomenclature, real-patient external validation, head-to-head benchmarking, explicit attention to data-pipeline and regulatory pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.